FREE CME 2017‑2018 | CMEList.com

 


Obesity: Expert Management Perspectives and Updates from Obesity Week
Live online November 11, 2016, and available on demand through May 11, 2017.
Posted by...Bernard Sklar, MD.Free Obesity CME
Free Obesity CME Credit hours...1.0. 
CME Credits Awarded by....Boston University School of Medicine..
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for primary care physicians, gastroenterologists, surgeons, pharmacists, nurses, nurse practitioners and other clinicians involved in the treatment and management of obesity.
Educational material updated... November 11, 2016.
Expiration of CME credit...May 11, 2017.
Financial Support...None
After viewing Obesity: Expert Management Perspectives, you will be better able to:
• Apply the approach that obesity is a disease, not a behavioral problem, and in that context more identify more effective collaborative methods to overcome patient barriers to following an optimized weight management plan
• Identify the indications for each of the spectrum of obesity treatments, including lifestyle interventions, pharmacotherapy, and surgery for individualized obesity management
• Describe the pharmacology of the currently available medications for obesity, their indications and adverse effect profile, and how to initiate and titrate them as part of an effective obesity treatment program
• Describe key clinical reports from Obesity Week 2016

The Best of Stroke Forum 2016  Free Stroke CME
Posted by...Bernard Sklar, MD. 
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Emergency medicine physicians, neurologists, emergency medicine residents, nurses, physician assistants, nurse practitioners, and other health care professionals involved in the treatment of patients with AIS.
Educational material last updated...November 10, 2016.
CME Credit Expires...November 9, 2017.
Financial Support...Genentech, Inc.
The Best of Stroke Forum 2016 consists of two brief lectures:
• Eligibility for IV Thrombolysis: A Review of Inclusion and Exclusion Criteria
• Stroke Therapy: Examining New Evidence
After competing The Best of Stroke Forum 2016, you should be better able to:
• Apply evidence-based criteria to the selection of candidates for thrombolytic therapy in AIS.
• Evaluate FDA labeling, current data, and clinical practice guidelines on the use of tissue plasminogen activator in the extended 3-hour to 4.5-hour post-onset window.
• Assess recent studies and guidelines on endovascular procedures for AIS.
• Determine the criteria for the concomitant or preferential use of tissue plasminogen activator in patients with AIS who are being considered for endovascular procedures.
• Incorporate shared decision making with patients and their families to improve education and assist in reducing delays in treatment and complications.

Updates in Alzheimer's Disease: An Expert Interview Series
Posted by...Bernard Sklar, MD.
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Primary care providers, neurologists, gerontologists, radiologists, nuclear medicine physicians, and other health care professionals involved in the treatment of patients with Alzheimer's disease.
Educational material last updated...October 11th, 2016.
CME Credit Expires...October 10th, 2017.
Financial Support...Lilly.
Updates in Alzheimer's Disease consists of two brief lectures:
• Emerging Therapies for the Treatment of Alzheimer's Disease
• Alzheimer's Disease: Updates on Diagnostics and Early-stage Management
After competing Updates in Alzheimer's Disease, you should be better able to:
• Evaluate evidence-based strategies for the early diagnosis of Alzheimer's disease.
• Review the latest data of the pathophysiology and management strategies for pre-symptomatic and mild Alzheimer's disease.
• Evaluate the latest safety and efficacy data for new and emerging agents for the treatment of Alzheimer's disease.

Improving Bone Strength and Reducing Fracture Risk in Osteoporosis
Posted by...Bernard Sklar, MD. Osteoporosis CME
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Endocrinologists, internal medicine physicians, and other health care professionals involved in the treatment of patients with osteoporosis.
Educational material last updated...September 1, 2016.
CME Credit Expires...August 31, 2017.
Financial Support...Merck & Co., Inc.
Improving Bone Strength and Reducing Fracture Risk in Osteoporosis consists of two brief video lectures on the causes and treatments of osteoporosis.
Upon successful completion of Improving Bone Strength and Reducing Fracture Risk in Osteoporosis, you should be better able to:
• Outline the mechanisms of action of currently available and emerging resorption inhibitors, anabolic agents, and other therapeutic options for osteoporosis.
• Assess screening and diagnostic modalities that allow for the prompt management of osteoporosis.

How Low Can You Go? LDL - Is Lower Really Better?
Posted by...Bernard Sklar, MD. cholesterol CME
Free CME Credit Hours...1.0.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Cardiologists, endocrinologists, primary care physicians, family physicians, internists, and other health care professionals involved in the treatment of patients with dyslipidemia.
Educational material last updated...August 25, 2016.
CME Credit Expires...August 24, 2017.
Financial Support...Amgen.
How Low Can You Go? LDL - Is Lower Really Better?  features interviews with clinical experts, who discuss newly released evidence and guidelines regarding cardiovascular risk assessment, best practices when evaluating patients with elevated LDL-C, clinical study data pertaining to the effects of lowering LDL-C beyond evidence-based recommendations, and use of non-statin therapies for the treatment of dyslipidemia in patients who cannot achieve desired target levels.
Upon successful completion of How Low Can You Go? LDL - Is Lower Really Better?, you should be better able to:
• Incorporate cardiovascular risk assessment, evidence-based guidelines, and best practices when evaluating patients with elevated LDL-C.
• Assess clinical study data pertaining to the effect of lowering LDL-C beyond evidence-based recommendations and its effect on cardiovascular risk reduction.
• Evaluate the use of non-statin therapies for the treatment of dyslipidemia in patients who are intolerant or in patients who cannot achieve desired target levels. • Incorporate therapeutic regimens with demonstrated ability to reduce risk markers other than LDL-C.
• Incorporate therapeutic regimens with demonstrated ability to reduce risk markers other than LDL-C.

Advances in Heart Failure Management: Improving Outcomes with Innovation Frree Cardiology CME
Live online September 27, 2016, and November 1, 2016 and available on demand through May 1, 2017.
Posted by...Bernard Sklar, MD.
Free Cardiology CME Credit hours...3.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for cardiologists, interventional cardiologists, internal medicine and primary care physicians, and other health care professionals who treat patients with heart failure.
Educational material updated... June 9, 2016.
Expiration of CME credit... May 1, 2017.
Financial Support...Novartis Pharmaceutical Corporation.
At the conclusion of Advances in Heart Failure Management, you will be able to:
• Implement heart failure classification systems, such as the ACC/AHA stages or NYHA functional classification, in order to effectively stage patients and direct treatment goals
• Evaluate the role of biomarkers as prognostic indicators, and to monitor therapy for patients with reduced or preserved ejection fraction heart failure
• Implement pivotal study data for recently approved therapies for patients with heart failure
• Evaluate pivotal study data for recently approved therapies for patients with heart failure
• Implement electricity and catheter-based therapies for heart failure patients who are appropriate candidates
• Appraise clinical trial data for emerging interventions for patients with advanced heart failure
• Compare and contrast clinical trial data for emerging therapies and interventions
• Prescribe evidence-based approaches to real heart failure cases

The Rising Role of the PCP in HCV Diagnosis and Treatment Free Infectious Disease CME
Posted by...Bernard Sklar, MD.
Free Infectious Disease CME Credit Hours...0.75.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Primary care physicians, family physicians/general practitioners, internal medicine physicians, infectious disease specialists, gastroenterologists, hepatologists and other health care professionals involved in the treatment and management of HCV.
Educational material last updated...May 31, 2016.
CME Credit Expires...May 31, 2017.
Financial Support...Gilead Sciences Medical Affairs.
The Rising Role of the PCP in HCV Diagnosis and Treatment consists of 3 brief lectures on the early diagnosis and treatment of hepatitis C infection:
• HCV Today: The Importance of Early Detection and Intervention
• How the HCV Treatment Revolution Impacts Primary Care Practice
• HCV Treatment in Primary Care: What the First-time Treater Needs to Know
After completing The Rising Role of the PCP in HCV Diagnosis and Treatment, you should be better able to:
• Evaluate the impact of early detection and intervention for patients with HCV on preventing disease progression, improving extrahepatic manifestations, and achieving cure.
• Apply established screening guidelines to the early and accurate detection of HCV.
Identify patients with HCV infection who may be easily treated in the primary care setting or refer to a specialist as warranted.
• Implement effective follow-up, counseling, and quality care for patients upon confirmed diagnosis of HCV.
• Differentiate new agents for HCV management based on safety, efficacy, and recommended usage.
• Apply evidence-based treatment guidelines to the effective management of patients with HCV.

The Newest in Non-Small Cell Lung Cancer (NSCLC): Emerging Therapies, Novel Approaches, Therapeutic Updates, and Barriers to Care and Incorporating Best Practice Lung Cancer CME
Posted by...Bernard Sklar, MD.  
Oncology CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Format...Online Video.
Target Audience...Healthcare professionals specializing in: interventional radiology; nuclear medicine; oncology; palliative care; pathology; pulmonology; or those who otherwise commonly care for patients with NSCLC.
Educational material last updated....May 9, 2016
Expiration of CME credit...May 9, 2018.
Financial Support...Boehringer Ingelheim.
The Newest in Non-Small Cell Lung Cancer (NSCLC) has been designed to bring your knowledge of the rationale behind treatment of NSCLC up to date and to enhance your competence in caring for patients with NSCLC. 
After viewing The Newest in Non-Small Cell Lung Cancer (NSCLC), you will be better able to:
• Describe the impact of biomarker and mutation testing and their results for the management of patients with NSCLC and apply this knowledge to patient cases.
• Describe the role and impact of the initial biopsy, including the relevance of its timing and factors affecting quality of results.
• Distinguish between different NSCLC disease subtypes on the basis of histology, biomarker, and mutation status and use the information to optimize care in the setting of patient cases.
• Discuss the ways that NSCLC has proved resistant to treatments in past and the mechanisms of action of targeted therapies, present and emerging.
In order to get credit from ScientiaCME, you must first establish a username and password.

Alzheimer Disease (AD) and Its Complications: Best Practices, Emerging Therapies, and Barriers to Care Alzheimer's Disease CME
Posted by...Bernard Sklar, MD.
Alzheimer's Disease CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture.
Target Audiences...Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.
Educational material updated...December 21, 2015.
Expiration of CME credit...December 21, 2017.
Financial Support...AVANIR.
Topics covered in Alzheimer Disease (AD) and Its Complications include:
Epidemiology of and risk factors for Alzheimer Disease (AD), Symptomatology and diagnosis of AD, Treatment in patients with AD, Complications and barriers to optimal care in patients with AD and many more.
After completing Alzheimer Disease (AD) and Its Complications, you will be able to:
• Describe what is presently known about the pathophysiology of AD and the challenges associated with diagnosis and treatment of AD.
• Evaluate a treatment plan for a specific patient based on degree of AD to optimize safety and efficacy, suggesting modifications for improvement.
• Identify the present treatment options currently available for management of AD and apply them to patient cases using evidence-based medicine.
• Describe emerging drug therapies in the treatment of AD.
• Describe barriers to care and suggest therapies for treating cognitive and behavioral complications secondary to AD